Test Rapido Covid-19
COVID-19 IgG/IgM Rapid Test
Cat # R0180C**
- The OnSite COVID-19 IgG/IgM Rapid Test is designed for initial screening by detecting anti-SARS-CoV-2 IgG and IgM antibodies in either human serum, plasma or whole blood within just 10 minutes.
- This test is easy-to-use, requires only minimally skilled personnel with basic equipment needs.
- The OnSite COVID-19 IgG/IgM Rapid Test has 96.9% sensitivity and 99.4% specificity making it one of the most effective screening tests for COVID-19.
**Precio Unitario x Test
**Pedido Minimo de 1 Caja de 20 Test x 9,50€ Total 190€ mas IVA.
DADA LA GRAN DEMANDA QUE TENEMOS ACTUALMENTE DE ESTOS KITS LAS COMPRAS SE ESTAN REALIZANDO POR RESERVAS, POR FAVOR ENVIAR MAIL A NUESTRO DELEGADO DAVID ADORNA PARA INDICARLES LAS CANTIDADES A RESERVAR, su mail es firstname.lastname@example.org
Test Rapido Covid-19
With cases of coronavirus COVID-19 disease rising at an unprecedented rate, CTK has taken their proven strength in developing infectious disease diagnostics and in collaboration with its partners in China, has proudly launched two diagnostic tests for this virus, both a real-time PCR based nucleic acid detection kit and a serological Test Rapido Covid-19 screening test, for the International market.
The virus (SARS-CoV-2) causing the COVID-19 disease is a new pathogen that can lead to severe acute respiratory syndrome (SARS). Unlike other infectious disease outbreaks seen so far, the SARS-CoV-2 has proven to spread faster and affect a wider range of population, stretching to every continent, infecting over 115,000 people and causing over 4,200 deaths during the last 3 months alone. It is vital to diagnose affected patients as quickly as possible for early containment and treatment. The World Health Organization (WHO) has officially declared that COVID-19 is now a pandemic.
WHO declared in the Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) as following: Development of rapid and accurate point-of-care tests which perform well in field settings are especially useful if the test can be incorporated into presently commercially available multiplex respiratory virus panels. This would markedly improve early detection and isolation of infected patients and by extension, identification of contacts. Rapid IgM and IgG antibody testing are also important ways to facilitate early diagnosis.